clonidine has been researched along with Renal Insufficiency, Chronic in 1 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garg, AX | 1 |
| Kurz, A | 1 |
| Sessler, DI | 1 |
| Cuerden, M | 1 |
| Robinson, A | 1 |
| Mrkobrada, M | 1 |
| Parikh, C | 1 |
| Mizera, R | 1 |
| Jones, PM | 1 |
| Tiboni, M | 1 |
| Rodriguez, RG | 1 |
| Popova, E | 1 |
| Rojas Gomez, MF | 1 |
| Meyhoff, CS | 1 |
| Vanhelder, T | 1 |
| Chan, MT | 1 |
| Torres, D | 1 |
| Parlow, J | 1 |
| de Nadal Clanchet, M | 1 |
| Amir, M | 1 |
| Bidgoli, SJ | 1 |
| Pasin, L | 1 |
| Martinsen, K | 1 |
| Malaga, G | 1 |
| Myles, P | 1 |
| Acedillo, R | 1 |
| Roshanov, P | 1 |
| Walsh, M | 1 |
| Dresser, G | 1 |
| Kumar, P | 1 |
| Fleischmann, E | 1 |
| Villar, JC | 1 |
| Painter, T | 1 |
| Biccard, B | 1 |
| Bergese, S | 1 |
| Srinathan, S | 1 |
| Cata, JP | 1 |
| Chan, V | 1 |
| Mehra, B | 1 |
| Leslie, K | 1 |
| Whitlock, R | 1 |
| Devereaux, PJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Large, International, Placebo-controlled, Factorial Trial to Assess the Impact of Clonidine and Acetyl-salicylic Acid (ASA) in Patients Undergoing Noncardiac Surgery Who Are at Risk of a Perioperative Cardiovascular Event[NCT01082874] | Phase 3 | 10,010 participants (Actual) | Interventional | 2010-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01082874)
Timeframe: 30 days
| Intervention | participants (Number) |
|---|---|
| Active Clonidine and Active ASA | 173 |
| Active Clonidine and Placebo ASA | 194 |
| Placebo Clonidine and Active ASA | 178 |
| Placebo Clonidine and Placebo ASA | 161 |
1 trial available for clonidine and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Aspirin and clonidine in non-cardiac surgery: acute kidney injury substudy protocol of the Perioperative Ischaemic Evaluation (POISE) 2 randomised controlled trial.
Topics: Acute Kidney Injury; Adrenergic alpha-2 Receptor Agonists; Anti-Inflammatory Agents, Non-Steroidal; | 2014 |